UnitedHealth Group Incorporated (NYSE:UNH) Receives $358.95 Average PT from Analysts

UnitedHealth Group Incorporated (NYSE:UNH) has received an average rating of “Hold” from the twenty-six brokerages that are presently covering the firm, MarketBeat reports. Four analysts have rated the stock with a sell recommendation, six have given a hold recommendation and sixteen have assigned a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $358.9545.

UNH has been the topic of a number of analyst reports. Oppenheimer dropped their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Barclays upped their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Morgan Stanley upped their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. KeyCorp lowered their target price on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UnitedHealth Group in a report on Saturday, September 27th.

Institutional Investors Weigh In On UnitedHealth Group

A number of institutional investors have recently added to or reduced their stakes in UNH. Citizens National Bank Trust Department lifted its holdings in shares of UnitedHealth Group by 1.0% in the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after purchasing an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH raised its holdings in shares of UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after acquiring an additional 1,465 shares in the last quarter. Caitlin John LLC raised its holdings in shares of UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after acquiring an additional 111 shares in the last quarter. Triumph Capital Management purchased a new stake in shares of UnitedHealth Group during the second quarter worth $1,324,000. Finally, Wealth Effects LLC raised its holdings in shares of UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after acquiring an additional 591 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $360.17 on Friday. UnitedHealth Group has a twelve month low of $234.60 and a twelve month high of $630.73. The stock has a market capitalization of $326.20 billion, a P/E ratio of 15.61, a PEG ratio of 2.34 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The business’s fifty day moving average price is $307.84 and its 200 day moving average price is $353.45.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts anticipate that UnitedHealth Group will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.